79 related articles for article (PubMed ID: 2523593)
21. Kinetics of antidonor mixed lymphocyte culture responses in donor specific transfusions plus azathioprine-treated patients.
Burlingham WJ; Grailer A; Sparks-Mackety EM; Sondel PM; Sollinger HW
Transplant Proc; 1987 Feb; 19(1 Pt 3):2255-7. PubMed ID: 2978892
[No Abstract] [Full Text] [Related]
22. Relationship of mixed lymphocyte culture (MLC) response and kidney graft survival in living related donor transplants.
Lazda VA; Jonasson O; Mozes MF
Transplant Proc; 1981 Mar; 13(1 Pt 2):949-52. PubMed ID: 6455829
[No Abstract] [Full Text] [Related]
23. Effect of HLA-DR matching between living kidney donors and recipients and of pretransplant blood transfusions on graft survival.
Akiyama N; Sugimoto H; Kusaba R; Takahashi I; Ohsawa N; Inou T; Samaru Y
Jpn J Exp Med; 1981 Feb; 51(1):37-43. PubMed ID: 6458714
[TBL] [Abstract][Full Text] [Related]
24. rhG-CSF effect on mixed lymphocyte cultures and circulating soluble HLA antigen levels in volunteer stem cell donors.
Lindemann M; Rebmann V; Ottinger HD; Schmolke K; Kreuzfelder E; Grosse-Wilde H
Exp Hematol; 2004 Nov; 32(11):1103-9. PubMed ID: 15539089
[TBL] [Abstract][Full Text] [Related]
25. Role of the mixed lymphocyte culture reaction in predicting acute graft-versus-host disease after marrow transplants from haploidentical and unrelated donors.
Mickelson EM; Anasetti C; Yoon Choo S; Longton GM; Petersdorf EW; Martin PJ; Hansen JA
Transplant Proc; 1993 Feb; 25(1 Pt 2):1239-40. PubMed ID: 8442101
[No Abstract] [Full Text] [Related]
26. Unrelated donor matching for bone marrow transplantation.
Chopek M; Alosco S; Salazar M; Yunis EJ
Transplant Proc; 1993 Feb; 25(1 Pt 2):1255-8. PubMed ID: 8442106
[TBL] [Abstract][Full Text] [Related]
27. Kidney graft survival and immunologic changes in patients conditioned with donor-specific transfusions prior to transplantation.
Bean MA; Mickelson E; Yanagida J; Ishioka S; Hansen JA
Transplant Proc; 1988 Dec; 20(6):1084-6. PubMed ID: 2974196
[No Abstract] [Full Text] [Related]
28. The Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCL) as stimulating cells in mixed lymphocyte culture (MLC).
Wasik M; Matej H; Duś D; Myc A
Arch Immunol Ther Exp (Warsz); 1983; 31(6):879-85. PubMed ID: 6331341
[TBL] [Abstract][Full Text] [Related]
29. The impact of low donor-specific MLR versus HLA-DR compatibility on kidney graft survival.
Langhoff E; Jakobsen BK; Platz P; Ryder LP; Svejgaard A
Transplantation; 1985 Jan; 39(1):18-21. PubMed ID: 2578235
[TBL] [Abstract][Full Text] [Related]
30. [Detection of HLA-DR, DQ and DP loci on monocytes using monoclonal antibodies].
Májský A
Cas Lek Cesk; 1987 Oct; 126(42):1313-6. PubMed ID: 3677160
[No Abstract] [Full Text] [Related]
31. [Significance of mixed lymphocyte culture (MLC) in renal transplants from living donors].
Zanuso C; Pontiero P; Ancona G; Galvani E; Confortini P
Minerva Chir; 1980 May; 35(10):791-2. PubMed ID: 6450337
[TBL] [Abstract][Full Text] [Related]
32. Mixed lymphocyte reaction and skin graft using HLA-DP and DQ transgenic mice.
Hagihara M; Shimura T; Tsuchida F; Takebe K; Munkhbat B; Tsuji K
Transplant Proc; 1994 Aug; 26(4):1868. PubMed ID: 8066607
[No Abstract] [Full Text] [Related]
33. Improved renal allograft survival following donor-specific transfusions. I. Induction of antibodies that inhibit primary antidonor MLC response.
Burlingham WJ; Sparks EM; Sondel PM; Glass NR; Belzer FO; Sollinger HW
Transplantation; 1985 Jan; 39(1):12-7. PubMed ID: 3155578
[TBL] [Abstract][Full Text] [Related]
34. Histocompatibility testing in clinical renal transplantation.
Braun WE
Urol Clin North Am; 1983 May; 10(2):231-42. PubMed ID: 6222529
[No Abstract] [Full Text] [Related]
35. Induction of suppressor T cells in vitro by an autologous alloreactive T cell line propagated from a DSBT-enhanced rat renal allograft.
Ruiz P; Baldwin WM; Sanfilippo F
Transplant Proc; 1989 Apr; 21(2):3289-91. PubMed ID: 2565616
[No Abstract] [Full Text] [Related]
36. [Maternal lymphocytes that are imprinted on the child's cells in primary mixed lymphocyte culture (MLC) are able to recognize paternal cells in secondary MLC].
Hajek-Rosenmayr A
Beitr Infusionther Klin Ernahr; 1987; 18():360-3. PubMed ID: 2964233
[No Abstract] [Full Text] [Related]
37. Effect of pretransplant donor-specific transfusions in renal transplantation.
Leivestad T; Flatmark A; Hirschberg H; Thorsby E
Transplant Proc; 1982 Jun; 14(2):370-3. PubMed ID: 6214064
[No Abstract] [Full Text] [Related]
38. The clinical significance of the autologous mixed lymphocyte reaction in transplantation.
Fuller L; Esquenazi V; Roth D; Milgrom M; Haynes M; Miller J
Transplant Proc; 1987 Feb; 19(1 Pt 2):1562-3. PubMed ID: 2978883
[No Abstract] [Full Text] [Related]
39. [HLA-compatibility testing in kidney transplantation--past, present and future].
van Rood JJ; Persijn GG; van Leeuwen A; Goulmy E; Lansbergen Q; Cohen B
Chirurg; 1980 May; 51(5):257-62. PubMed ID: 6447582
[No Abstract] [Full Text] [Related]
40. [The significance of mixed lymphocyte culture and mitogen-stimulated culture for kidney transplantation (author's transl)].
Hajek-Rosenmayr A; Wolf A
Wien Klin Wochenschr; 1981 Jul; 93(14):457-60. PubMed ID: 6455859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
